ClinicalTrials.gg

Program

ledaborbactam etzadroxil

Also written as “VNRX-7145” and “Ledaborbactam etzadroxil”.

Its studies are led by Basilea Pharmaceutica.

Furthest: phase 1, since Jan 14, 20205 company-led studies, 1 open or runningNext primary completion: Dec 30, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Basilea Pharmaceutica51 open or runningphase 1since Jan 14, 2020Jan 14, 2020Dec 30, 2026phase 1 · NCT06733675

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 14, 2020First study: phase 1 study in Healthy VolunteersFirst studyNCT04243863 · 83 enrolled · United States
  2. May 3, 2021Phase 1 study in Healthy SubjectsNCT04877379 · 53 enrolled · Netherlands
  3. Aug 3, 2022Phase 1 study in PharmacokineticsNCT05488678 · 32 enrolled · United States
  4. Sep 1, 2022Phase 1 study in PharmacokineticsNCT05527834 · 24 enrolled · United States
  5. Dec 10, 2024Phase 1 study in Healthy VolunteerNCT06733675 · 96 planned · United States

Ahead

  1. Dec 30, 2026Primary completion: phase 1 study in Healthy VolunteerNCT06733675

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06733675Healthy Volunteer · United States1RecruitingDec 30, 202696
NCT05527834Pharmacokinetics · United States1CompletedFeb 6, 202324
NCT05488678Pharmacokinetics · United States1CompletedNov 23, 202332
NCT04877379Healthy Subjects · Netherlands1CompletedNov 10, 202153
NCT04243863Healthy Volunteers · United States1CompletedApr 5, 202183

How it is read

Names in the registry

  • “VNRX-7145”, 4 entries
  • “Ledaborbactam etzadroxil”, 1 entry

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.